Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave advanced renal cell carcinoma
Neeraj Agarwal Huntsman Cancer Center discusses Phase 1b study (COSMIC-021) of cabozantinib in combination with atezolizumab:Results of the dose-escalation stage in patients with treatment-nave adv...
Author: kidneycancer
Added: 11/06/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Study | Urology & Nephrology